Carotid cross-sectional wall area is significantly associated with serum leptin levels, independent of body mass index: The SABPA study

Hypertension Research

Volumn 35, Issue 12, 2012, Pages 1185-1192

  Pieterse, Chiné ^a   Schutte, Alta E ^a   Mels, Carina ^a   Smith, Wayne ^a   Schutte, Rudolph ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

atherosclerosis; blood pressure; cross sectional wall area; ethnicity; leptin

Indexed keywords

LEPTIN;

ADULT; AFRICAN AMERICAN; ARTERY DIAMETER; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR FUNCTION; CAUCASIAN; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 84870789669     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.130     Document Type: Article

References (54)

1. Addo J, Smeeth L, Leon DA. Hypertension in sub-saharan Africa: a systematic review.Hypertension 2007; 50: 1012-1018.
2. Poulter NR. Current and projected prevalence of arterial hypertension in sub-SaharanAfrica by sex, age and habitat: an estimate from population studies. J Hypertens 2011;29: 1281-1282.
3. Twagirumukiza M, De BD, Kips JG, de BG, Stichele RV, Van Bortel LM. Current andprojected prevalence of arterial hypertension in sub-Saharan Africa by sex, age andhabitat: an estimate from population studies. J Hypertens 2011; 29: 1243-1252.
4. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation2005; 112: 3562-3568.
5. Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D. Leptin: linking obesity,the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep 2008; 10:131-137.
6. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release ofadipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral andsubcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145:2273-2282.
7. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L,Trimarco V, Trimarco B, Lembo G. Leptin effect on endothelial nitric oxide is mediatedthrough Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002;51: 168-173.
8. Quehenberger P, Exner M, Sunder-Plassmann R, Ruzicka K, Bieglmayer C, Endler G,Muellner C, Speiser W, Wagner O. Leptin induces endothelin-1 in endothelial cellsin vitro. Circ Res 2002; 90: 711-718.
9. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress inhuman endothelial cells. FASEB J 1999; 13: 1231-1238.
10. Koh KK, Quon MJ, Lee SJ, Han SH, Ahn JY, Kim JA, Chung WJ, Lee Y, Shin EK.Efonidipine simultaneously improves blood pressure, endothelial function, and metabolicparameters in nondiabetic patients with hypertension. Diabetes Care 2007; 30:1605-1607.
11. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB,Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immuneresponses. FASEB J 1998; 12: 57-65.
12. Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: response totherapeutic interventions. Circulation 2008; 117: 3238-3249.
13. Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL. The concept ofselective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002;51: 439-442.
14. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006; 189: 47-60.
15. Konstantinides S, Schafer K, Koschnick S, Loskutoff DJ. Leptin-dependent plateletaggregation and arterial thrombosis suggests a mechanism for atherothromboticdisease in obesity. J Clin Invest 2001; 108: 1533-1540.
16. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovasculardisease. Nature 2006; 444: 875-880.
17. Schulze PC, Kratzsch J. Leptin as a new diagnostic tool in chronic heart failure. ClinChim Acta 2005; 362: 1-11.
18. Imholz BP, Wieling W, van Montfrans GA, Wesseling KH. Fifteen years experience withfinger arterial pressure monitoring: assessment of the technology. Cardiovasc Res1998; 38: 605-616.
19. Guelen I, Westerhof BE, van der Sar GL, van Montfrans GA, Kiemeneij F, Wesseling KH,Bos WJ. Validation of brachial artery pressure reconstruction from finger arterialpressure. J Hypertens 2008; 26: 1321-1327.
20. Schutte AE, Huisman HW, van Rooyen JM, Malan NT, Schutte R. Validation of theFinometer device for measurement of blood pressure in black women. J HumHypertens 2004; 18: 79-84.
21. Schutte AE, Huisman HW, van Rooyen JM, Oosthuizen W, Jerling JC. Sensitivity of theFinometer device in detecting acute and medium-term changes in cardiovascularfunction. Blood Press Monit 2003; 8: 195-201.
22. AAMI. American National Standard for Electronic or Automated Sphygmomanometers.Association for the Advancement for Medical Instrumentation, Arlington, 2002.
23. Wesseling KH, Jansen JR, Settels JJ, Schreuder JJ. Computation of aortic flow frompressure in humans using a nonlinear, three-element model. J Appl Physiol 1993; 74:2566-2573.
24. Langewouters GJ, Wesseling KH, Goedhard WJ. The static elastic properties of 45human thoracic and 20 abdominal aortas in vitro and the parameters of a new model.J Biomech 1984; 17: 425-435.
25. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L,Desvarieux M, Ebrahim S, Fatar M, Hernandez HR, Jaff M, Kownator S, Prati P,Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F,Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). Anupdate on behalf of the Advisory Board of the 3rd and 4th Watching the RiskSymposium, 13th and 15th European Stroke Conferences, Mannheim, Germany,2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75-80.
26. Liang Q, Wendelhag I, Wikstrand J, Gustavsson T. A multiscale dynamic programmingprocedure for boundary detection in ultrasonic artery images. IEEE Trans Med Imaging2000; 19: 127-142.
27. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerizedanalyzing system simplifies readings and reduces the variability in ultrasoundmeasurement of intima-media thickness. Stroke 1997; 28: 2195-2200.
28. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Relation of arterialstructure and function to left ventricular geometric patterns in hypertensive adults.J Am Coll Cardiol 1996; 28: 751-756.
29. Roman MJ, Kizer JR, Best LG, Lee ET, Howard BV, Shara NM, Devereux RB. Vascularbiomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study.Hypertension 2012; 59: 29-35.
30. Norton K, Olds T. Anthropometrica: A Textbook of Body Measurements for Sport andHealth Courses. Sydney, UNSW Press, 1996.
31. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. High-throughputspectrophotometric assay of reactive oxygen species in serum. Mutat Res 2007; 631:55-61.
32. Herzum I, Rieger T, Funke J. Evaluation of the consolidated Beckman Coulter UniCelDxC 880i analyzer-A. Clin Chem Lab Med 2008; 46: A72.
33. Ciccone M, Vettor R, Pannacciulli N, Minenna A, Bellacicco M, Rizzon P, Giorgino R,De PG. Plasma leptin is independently associated with the intima-media thickness ofthe common carotid artery. Int J Obes Relat Metab Disord 2001; 25: 805-810.
34. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE.Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol2003; 157: 25-31.
35. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M. Low gradeinflammation in juvenile obesity and type 1 diabetes associated with early signs ofatherosclerosis. Exp Clin Endocrinol Diabetes 2004; 112: 378-382.
36. Bodary PF, Gu S, Shen Y, Hasty AH, Buckler JM, Eitzman DT. Recombinant leptinpromotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice.Arterioscler Thromb Vasc Biol 2005; 25: e119-e122.
37. Kozakova M, Palombo C, Paterni M, Anderwald CH, Konrad T, Colgan MP, Flyvbjerg A,Dekker J. Body composition and common carotid artery remodeling in a healthypopulation. J Clin Endocrinol Metab 2008; 93: 3325-3332.
38. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M. Leptin inducesmitochondrial superoxide production and monocyte chemoattractant protein-1 expressionin aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.J Biol Chem 2001; 276: 25096-25100.
39. Beltowski J, Wojcicka G, Jamroz A. Leptin decreases plasma paraoxonase 1 (PON1)activity and induces oxidative stress: the possible novel mechanism for proatherogeniceffect of chronic hyperleptinemia. Atherosclerosis 2003; 170: 21-29.
40. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease.Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
41. Zeidan A, Purdham DM, Rajapurohitam V, Javadov S, Chakrabarti S, Karmazyn M.Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II-andendothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy.J Pharmacol Exp Ther 2005; 315: 1075-1084.
42. Yanagitani Y, Rakugi H, Okamura A, Moriguchi K, Takiuchi S, Ohishi M, Suzuki K,Higaki J, Ogihara T. Angiotensin II type 1 receptor-mediated peroxide production inhuman macrophages. Hypertension 1999; 33: 335-339.
43. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992; 19:753-757.
44. Lindgarde F, Soderberg S, Olsson T, Ercilla MB, Correa LR, Ahren B. Overweight isassociated with lower serum leptin in Peruvian Indian than in Caucasian women:A dissociation contributing to low blood pressure? Metabolism 2001; 50: 325-329.
45. Shankar A, Xiao J. Positive relationship between plasma leptin level and hypertension.Hypertension 2010; 56: 623-628.
46. Takizawa H, Ura N, Saitoh S, Wang L, Higashiura K, Takagi S, Takada M, Togashi N,Nakano M, Hayashi Y, Shimamoto K. Gender difference in the relationships amonghyperleptinemia, hyperinsulinemia, and hypertension. Clin Exp Hypertens 2001; 23:357-368.
47. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE, HeimanML, Birkett M, Attanasio AM, Kiess W, Rascher W. Plasma leptin levels in healthychildren and adolescents: dependence on body mass index, body fat mass, gender,pubertal stage, and testosterone. J Clin Endocrinol Metab 1997; 82: 2904-2910.
48. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides inobesity-associated hypertension. J Mol Med 2001; 79: 21-29.
49. Bovet P, Ross AG, Gervasoni JP, Mkamba M, Mtasiwa DM, Lengeler C, Whiting D,Paccaud F. Distribution of blood pressure, body mass index and smoking habits in theurban population of Dar es Salaam, Tanzania, and associations with socioeconomicstatus. Int J Epidemiol 2002; 31: 240-247.
50. Donahue RP, Zimmet P, Bean JA, Decourten M, Carlo Donahue RA, Collier G,Goldberg RB, Prineas RJ, Skyler J, Schneiderman N. Cigarette smoking,alcohol use, and physical activity in relation to serum leptin levels in amultiethnic population: The Miami Community Health Study. Ann Epidemiol 1999;9: 108-113.
51. Iputo JE, Robinson D, Mguni M. Serum leptin concentration in a rural Africanpopulation. East Afr Med J 2001; 78: 484-488.
52. Schutte R, Huisman HW, Schutte AE, Malan NT. Leptin is favourably associated withvascular function in obese Caucasians, but not in obese Africans. J Hum Hypertens2005; 19: 933-939.
53. Nicklas BJ, Toth MJ, Goldberg AP, Poehlman ET. Racial differences in plasma leptinconcentrations in obese postmenopausal women. J Clin Endocrinol Metab 1997; 82:315-317.
54. Tittelbach TJ, Berman DM, Nicklas BJ, Ryan AS, Goldberg AP. Racial differences inadipocyte size and relationship to the metabolic syndrome in obese women. Obes Res2004; 12: 990-998.